Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 2, 2019

View Archived Issues

World AIDS Day: Immediate ART initiation for neonates with HIV-1 provides significant benefits

New selective and potent mTOR inhibitor discovered through structure-based drug design

Evaluation of neuronal responses to La Crosse virus infection in human cerebral organoids

Chidamide approved in China for breast cancer indication

Takeda presents 18-month data from pivotal phase III TIDES study of TAK-003 dengue vaccine

Apatinib demonstrates safety and efficacy in phase II study in adenocarcinoma of the head and neck

Roche publishes data from iMATRIX study of atezolizumab

MiR-125b as a novel target in diabetes

Avidin describes new apoptosis inducers

Shenzhen Salubris Pharmaceuticals identifies new PAR-4 antagonists

Beijing Innocare Pharmaceutical Technology patents VEGFR inhibitors

New prostanoid EP3 receptor antagonists synthesized at Bayer

IBD Therapeutics discloses TRPM8 and TrpV1 antagonists/opioid receptor agonists

Mouse model reveals role of Rap1A in heart function

Developmental origins of pediatric brain tumors

Study links long non-coding RNAs to pulmonary hypertension

Vi-DT typhoid conjugate vaccine begins phase III study in Nepal

Pharmacodynamic responses seen with RNA interference therapy ARO-ANG3 in healthy volunteers

Aslan reports preliminary proof-of-concept data on ASLAN-004 in atopic dermatitis

Proof-of-concept study of SENS-111 in acute unilateral vestibulopathy misses primary endpoint

Concert initiates phase II study of CTP-692 as adjunctive treatment in schizophrenia

Phase IIb trial of Amphora for prevention of chlamydia and gonorrhea meets primary endpoint

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
Anticancer drug exerts potent HIV antiviral effects
BioWorld Science
A new isoform of proliferating cell nuclear antigen (PCNA) – cancer-associated PCNA (caPCNA) – that is specifically expressed in cancer tissues has been reported....